This case was reported by a consumer via other manufacturer and described the occurrence of psychotic episode in a female patient who received Influenza vaccine. Co-suspect products included aripiprazole for schizophrenia and Tetanus vaccine. Previously administered products included HALDOL with an associated reaction of alopecia and PROLIXIN with an associated reaction of alopecia. Concurrent medical conditions included schizophrenia. In 2015, the patient received Influenza vaccine. On an unknown date, the patient started aripiprazole at an unknown dose and frequency. In 2015, the patient received Tetanus vaccine. In 2015, an unknown time after receiving Influenza vaccine, the patient experienced psychotic episode (serious criteria hospitalization) and drug interaction. On an unknown date, the outcome of the psychotic episode was recovered/resolved and the outcome of the drug interaction was unknown. It was unknown if the reporter considered the psychotic episode and drug interaction to be related to Influenza vaccine. Additional details were received as follows: The patient's medical history includes HALDOL and PROLIXIN which lead to alopecia, hair growing slowly and thinning hair. In 2014, the patient started to receive ABILIFY MAINTENA (400 mg) with unknown frequency. It was unknown if it was single vial or dual chamber. The sample was not available as it was administered. It was unknown if the ABILIFY MAINTENA was administered by a healthcare professional. The site of administration was unknown.  It was unknown if the dose was 1st dose or the dates of the previous doses were unknown. It was unknown if the doses were prepared according to the prescribing information (PI) and reference guide. It was unknown if any physical defects were noted during preparation of product or in the kit. It was unknown if there were any unusual observations noted during administration. In 2015, the patient started ABILIFY (30 mg) daily for unknown indication. The patient reported that, ABILIFY MAINTENA worked great for her as in, it got her thinking going and she became relaxed and felt overall well mentally. On an unknown date, she began experiencing thinning hair, hair growing slowly and alopecia. In 2015, the patient received Influenza vaccine and Tetanus vaccine. It was reported that, Influenza and Tetanus vaccines diluted the ABILIFY MAINTENA out of her blood, which was also described as the vaccines lessened the ABILIFY MAINTENA in her blood. When ABILIFY MAINTENA, was diluted, the patient's hair got healthier. In late October 2015 or early November 2015, the patient had psychotic episode because ABILIFY MAINTENA was diluted out of her system and she was subsequently admitted to the hospital, where she started to receive ABILIFY 30 mg daily and ABILIFY MAINTENA was not given in the hospital. The patient reported that, ABILIFY made her extremely hungry and made her feel depressed and it was unknown if there was any relevant data. The patient was not receiving ABILIFY MAINTENA at the time of reporting. At the time of reporting, the thinning hair, hair growing slowly and alopecia were recovering. The reporter denied the consent to be contacted for follow up. So, no further information was available.